122 related articles for article (PubMed ID: 38456298)
1. CNP Ameliorates Macrophage Inflammatory Response and Atherosclerosis.
Bao Q; Zhang B; Zhou L; Yang Q; Mu X; Liu X; Zhang S; Yuan M; Zhang Y; Che J; Wei W; Liu T; Li G; He J
Circ Res; 2024 Apr; 134(8):e72-e91. PubMed ID: 38456298
[TBL] [Abstract][Full Text] [Related]
2. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
3. Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE
Shang Y; Ma C; Zhang J; Wang Z; Ren C; Luo X; Peng R; Liu J; Mao J; Shi Y; Fan G
Theranostics; 2020; 10(22):10231-10244. PubMed ID: 32929345
[No Abstract] [Full Text] [Related]
4. Hypoxia-Inducible Factor-1α Expression in Macrophages Promotes Development of Atherosclerosis.
Aarup A; Pedersen TX; Junker N; Christoffersen C; Bartels ED; Madsen M; Nielsen CH; Nielsen LB
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1782-90. PubMed ID: 27444197
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible protein 2 Hig2/Hilpda mediates neutral lipid accumulation in macrophages and contributes to atherosclerosis in apolipoprotein E-deficient mice.
Maier A; Wu H; Cordasic N; Oefner P; Dietel B; Thiele C; Weidemann A; Eckardt KU; Warnecke C
FASEB J; 2017 Nov; 31(11):4971-4984. PubMed ID: 28760743
[TBL] [Abstract][Full Text] [Related]
6. Metformin attenuates atherosclerosis and plaque vulnerability by upregulating KLF2-mediated autophagy in apoE
Wu H; Feng K; Zhang C; Zhang H; Zhang J; Hua Y; Dong Z; Zhu Y; Yang S; Ma C
Biochem Biophys Res Commun; 2021 Jun; 557():334-341. PubMed ID: 33915432
[TBL] [Abstract][Full Text] [Related]
7. Macrophage ALDH2 (Aldehyde Dehydrogenase 2) Stabilizing Rac2 Is Required for Efferocytosis Internalization and Reduction of Atherosclerosis Development.
Zhang J; Zhao X; Guo Y; Liu Z; Wei S; Yuan Q; Shang H; Sang W; Cui S; Xu T; Yang K; Guo J; Pan C; Wang J; Pang J; Han T; Chen Y; Xu F
Arterioscler Thromb Vasc Biol; 2022 Jun; 42(6):700-716. PubMed ID: 35354308
[TBL] [Abstract][Full Text] [Related]
8. CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice.
Gutiérrez-Muñoz C; Méndez-Barbero N; Svendsen P; Sastre C; Fernández-Laso V; Quesada P; Egido J; Escolá-Gil JC; Martín-Ventura JL; Moestrup SK; Blanco-Colio LM
FASEB J; 2020 Nov; 34(11):14960-14976. PubMed ID: 32924185
[TBL] [Abstract][Full Text] [Related]
9. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.
Dai XY; Cai Y; Sun W; Ding Y; Wang W; Kong W; Tang C; Zhu Y; Xu MJ; Wang X
Cardiovasc Res; 2014 Feb; 101(2):297-305. PubMed ID: 24253523
[TBL] [Abstract][Full Text] [Related]
10. miR-223-3p Prevents Necroptotic Macrophage Death by Targeting Ripk3 in a Negative Feedback Loop and Consequently Ameliorates Advanced Atherosclerosis.
Jia Y; Cheng L; Yang J; Mao J; Xie Y; Yang X; Zhang X; Wang D; Zhao Z; Schober A; Wei Y
Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):218-237. PubMed ID: 37970714
[TBL] [Abstract][Full Text] [Related]
11. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
[TBL] [Abstract][Full Text] [Related]
12. Vav Guanine nucleotide exchange factors regulate atherosclerotic lesion development in mice.
Rahaman SO; Li W; Silverstein RL
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2053-7. PubMed ID: 23825362
[TBL] [Abstract][Full Text] [Related]
13. CD147 Sparks Atherosclerosis by Driving M1 Phenotype and Impairing Efferocytosis.
Lv JJ; Wang H; Zhang C; Zhang TJ; Wei HL; Liu ZK; Ma YH; Yang Z; He Q; Wang LJ; Duan LL; Chen ZN; Bian H
Circ Res; 2024 Jan; 134(2):165-185. PubMed ID: 38166463
[TBL] [Abstract][Full Text] [Related]
14. IL-33 reduces macrophage foam cell formation.
McLaren JE; Michael DR; Salter RC; Ashlin TG; Calder CJ; Miller AM; Liew FY; Ramji DP
J Immunol; 2010 Jul; 185(2):1222-9. PubMed ID: 20543107
[TBL] [Abstract][Full Text] [Related]
15. Nicotine potentiates proatherogenic effects of oxLDL by stimulating and upregulating macrophage CD36 signaling.
Zhou MS; Chadipiralla K; Mendez AJ; Jaimes EA; Silverstein RL; Webster K; Raij L
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H563-74. PubMed ID: 23748423
[TBL] [Abstract][Full Text] [Related]
16. Calycosin ameliorates atherosclerosis by enhancing autophagy via regulating the interaction between KLF2 and MLKL in apolipoprotein E gene-deleted mice.
Ma C; Wu H; Yang G; Xiang J; Feng K; Zhang J; Hua Y; Kang L; Fan G; Yang S
Br J Pharmacol; 2022 Jan; 179(2):252-269. PubMed ID: 34713437
[TBL] [Abstract][Full Text] [Related]
17. Neopterin Counters Vascular Inflammation and Atherosclerosis.
Shirai R; Sato K; Yamashita T; Yamaguchi M; Okano T; Watanabe-Kominato K; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29420219
[TBL] [Abstract][Full Text] [Related]
18. Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis.
Bruen R; Curley S; Kajani S; Crean D; O'Reilly ME; Lucitt MB; Godson CG; McGillicuddy FC; Belton O
Cardiovasc Diabetol; 2017 Nov; 16(1):143. PubMed ID: 29110715
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein A1 Protects Against Necrotic Core Development in Atherosclerotic Plaques: PDZK1-Dependent High-Density Lipoprotein Suppression of Necroptosis in Macrophages.
Kluck GEG; Qian AS; Sakarya EH; Quach H; Deng YD; Trigatti BL
Arterioscler Thromb Vasc Biol; 2023 Jan; 43(1):45-63. PubMed ID: 36353992
[TBL] [Abstract][Full Text] [Related]
20. Anti-Atherogenic Effects of Vaspin on Human Aortic Smooth Muscle Cell/Macrophage Responses and Hyperlipidemic Mouse Plaque Phenotype.
Sato K; Shirai R; Yamaguchi M; Yamashita T; Shibata K; Okano T; Mori Y; Matsuyama TA; Ishibashi-Ueda H; Hirano T; Watanabe T
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
